Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese ...

The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...

China's investigation of AstraZeneca's top executive in the country is raising questions about the company's tactics there.

The pharmaceutical giant, whose China chief is now under investigation, was previously at the centre of insurance scam cases, ...

AstraZeneca’s China president is under investigation in mainland China, the drug company said on Wednesday. Leon Wang was ...

BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” ...

AstraZeneca said on Wednesday that to its knowledge an ongoing investigation by Chinese authorities into the company's top executive in the country, Leon Wang, is separate from a large health ...

AstraZeneca said on Wednesday that to its knowledge an ongoing investigation by Chinese authorities into the company's top ...

AstraZeneca stock tumbles as Chinese probe widens, implicating executives in insurance fraud and drug import violations ...

AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...

【环球时报-环球网报道 记者 白云怡】英国与瑞典合资的生物制药公司阿斯利康（AstraZeneca）30日发布公告指，其中国区的总裁王磊（Leon Wang）“正在配合中国政府接受调查”。在10月31日的外交部例行记者会上，有记者就此向中国外交部发言人提问。 对此，中国外交部发言人林剑回应表示，有关情况建议向中方的主管部门了解。“我在这里要指出的是，中国政府欢迎外国企业在华投资经营，将依法保障他们 ...